Sinovac Biotech Ltd. Adjoins Special Meeting Pending Resolution of Litigation

Strategic Insights -

Shareholders in Sinovac Biotech Ltd. convened for a Special Meeting on July 9, 2025, only to have it adjourned due to ongoing litigation related to the validity of shares issued following an invalid private investment in public equity (PIPE) to Advantech/Prime and Vivo Capital. The litigation centers around an Antigua court decision that prohibited the holders of these PIPE shares from voting at the meeting. The Board of Directors has assured shareholders that they will continue to prioritize dividend distributions, work with NASDAQ to resume trading, and explore a future listing on the Stock Exchange of Hong Kong.

Key Takeaways:

  • The Special Meeting of Shareholders was adjourned pending the resolution of litigation in Antigua related to the validity of shares issued following an invalid PIPE transaction to Advantech/Prime and Vivo Capital.
  • The Antigua Court granted an interim injunction prohibiting the holders of the PIPE shares from voting those shares at the meeting, pending the determination of the court's jurisdiction and the validity of those shares.
  • The Eastern Caribbean Court of Appeal temporarily stayed the injunction order, allowing the PIPE share holders to vote their shares at the meeting.
  • The Board of Sinovac Biotech Ltd. has a fiduciary duty to respond to all legal proceedings on behalf of the Company and implement the Privy Council's judgment and order.
  • The Board will continue to prioritize dividend distributions according to its previously announced policy and work with NASDAQ to resume trading.
  • The Company is exploring a future listing on the Stock Exchange of Hong Kong to promote liquidity and maximize value creation.

Statistics:

  • 8:00 a.m. China Standard Time (July 9, 2025) was the scheduled time for the Special Meeting of Shareholders.
  • Tuesday, July 8, 2025 at 8:00 p.m. Atlantic Standard Time was the equivalent scheduled time for the United States.
  • January 2025 was the month the UK Privy Council deemed the former board of Sinovac Biotech Ltd. as an "Imposter Board."
  • July 7, 2025, was the date the Antigua Court granted an interim injunction prohibiting the holders of the PIPE shares from voting those shares at the Special Meeting.

Sources:

  • Sinovac Biotech Ltd. - The Board of Directors of Sinovac Biotech Ltd. (https://www.sinovac.com/)
  • NASDAQ - NASDAQ Announcements (https://ir.nasdaq.com/)
  • Eastern Caribbean Supreme Court of Antigua and Barbuda (https://www.supremecourt.ag/)
  • Stock Exchange of Hong Kong (https://www.hkex.com.hk/)